Benzinga | Nov 8, 2021 10:01AM EST

Recro Pharma Earnings Preview

Recro Pharma (NASDAQ:REPH) is set to give its latest quarterly earnings report on Tuesday, 2021-11-09. Here's what investors need to know before the announcement.

Analysts estimate that Recro Pharma will likely report an Earnings Per Share (EPS) of $-0.07

Recro Pharma bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed on EPS by -127.27%, which was followed by a 4.59% increase in the share price the next day.

Here's a look at Recro Pharma's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020EPS Estimate -0.11 -0.25 -0.25 -0.20EPS Actual 0.03 -0.23 -0.48 -0.09Price Change % 4.59% 16.33% -30.14% -9.09%

Stock Performance

Shares of Recro Pharma were trading at $1.95 as of November 04. Over the last 52-week period, shares are up 8.33%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.